Indianapolis-based Lilly pleaded guilty to one violation of the Food, Drug and Cosmetic Act on Thursday and agreed to pay $1.42 billion to settle both that criminal charge as well as civil lawsuits in which it did not admit wrongdoing.
Doctors can still get free samples of medicines, but not football tickets or lunch for their spouses, under a revised code of conduct drafted by a global drug industry trade group that counts Eli Lilly as a member.
Ryan Kitchell, 38, replaces Marvin Pember, who left in July to take an executive position with Philadelphia-based hospital system Universal Health Services Inc.
Threats to cut federal Medicare funds that pay for residency training for doctors have eased but not gone away since they were formally proposed by some members of the Congressional super committee last fall. Dr. Peter Nalin, the associate dean of graduate medical education at the Indiana University School of Medicine, said such cuts would be disastrous at a time when patient demands increasingly outstrip the supply of physicians.
Franciscan St. Francis Health announced five years ago that it would consolidate its Beech Grove operations into an expanded hospital seven miles south, near Interstate 65 and Emerson Avenue. The last inpatient department to close at Beech Grove will be its emergency room, on March 16.
The Big 3 automakers spent 35 percent more in the Indianapolis area to provide health care for workers and non-elderly retirees than they did in other auto-heavy cities—and two-thirds of that difference can be blamed on “excess prices” by Indianapolis hospitals.
Eli Lilly and Co. plans to invest about $440 million in a new pharmaceutical plant at an existing company site in County Cork in southern Ireland. The facility in Kinsale will require as many as 200 skilled employees when fully operational.
3-D scans match former hospital with building plans.
Architects were told to push the envelope and integrate. Be mindful of where you are in the city and integrate well.
Excluding investment gains and one-time charges, CNO’s operations generated $60.1 million, or 22 cents per share, in the fourth quarter, up 16 percent from the same period last year.
The once fast-growing, Indianapolis-based disease-management company listed in court papers on Tuesday liabilities of nearly $5.7 million and assets of just $125,864.
The U.S. economy is showing signs of bouncing back and, if it does, look for drugmakers and medical-device companies to benefit. But if the economy has another summer stall like last year, expect health insurers to benefit.
After years of screaming by employers that spiraling health care spending is crimping their profits and forcing them to hold down wages, the economic impact study released last week by Indiana University Health suggests health care spending is an unmitigated blessing to the Indiana economy.
The city of Indianapolis approved the project after accepting Mainstreet Property Group’s offer to purchase the property at 16th Street and Arlington Avenue for $912,500.
Jon Mills previously worked for the late congresswoman Julia Carson, WellPoint Inc. and Indiana University Health.
Indiana is battling its second measles outbreak in two years, even though its vaccination rate exceeds the national average. Health officials say the cases, traced to a Super Bowl event, illustrate just how vulnerable the public is to exposure from sources at home and abroad.
Disease management company’s demise in August pushed its CEO Stephanie DeKemper into personal bankruptcy in late December and the company itself will file its own bankruptcy case as early as this week.
WellPoint Inc. finally canned the head of its consumer business after a string of disappointing results, and the move hasn’t further spooked the company’s jittery investors. Although that’s not saying much.
The Pink Ribbon Connection distinguishes its mission from one of the country’s most powerful health advocacy groups.
In the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies, an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national reports on life sciences.
